Device manufacturer, as written on reports
Allergan Pringy: medical device reports filed with FDA
8,714 reports name it as the manufacturer of the device involved, 2015–2026.
- 8,714
- reports naming it as manufacturer
- 0% of all MAUDE reports
- 48
- reports, 12 months to August 2026
- 217 in the 12 months before
- 15.1%
- classified as malfunction
- 62.3% across all reports
- 0%
- classified as death, as reported
- 0.9% across all reports
8,714 medical device reports received by FDA give Allergan Pringy as the manufacturer of the device involved, 0% of the MAUDE database, from February 2015 to August 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
48 reports arrived in the 12 months to August 2026, down 78% from 217 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (84.8%) and malfunction (15.1%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| Juvederm Voluma Xc/Lido Volume Unknown | Implant, dermal, for aesthetic use | 699 | 194 | 0.1% |
| Juvederm Voluma XC 27G 2 x 1mL | Implant, dermal, for aesthetic use | 664 | 78 | 0% |
| VOLBELLA with LIDOCAINE | Implant, dermal, for aesthetic use | 632 | 5 | 0.2% |
| Juvederm Ultra Xc Tsk Us | Implant, dermal, for aesthetic use | 560 | 1 | 0% |
| Unk Volbella | Implant, dermal, for aesthetic use | 510 | 70 | 0% |
| Juvederm VOLUMA WITH LIDOCAINE 1mL | Implant, dermal, for aesthetic use | 507 | 23 | 0% |
| VOLIFT with LIDOCAINE | Implant, dermal, for aesthetic use | 426 | 10 | 0% |
| Juvederm Volume/Concentration/Additive Unknown | Implant, dermal, for aesthetic use | 424 | 24 | 0.6% |
| JUVEDERM VOLLURE XC 2x1 mL | Implant, dermal, for aesthetic use | 388 | 24 | 0.5% |
| Juvederm Voluma Volume/Additive Unknown | Implant, dermal, for aesthetic use | 384 | 13 | 0% |
| Juvederm Ultra Plus Xc Tsk Us | Implant, dermal, for aesthetic use | 327 | 5 | 0% |
| Volift Volume Unknown | Implant, dermal, for aesthetic use | 290 | 52 | 0.3% |
| Juvederm Voluma With Lidocaine 1ml Sku1 | Implant, dermal, for aesthetic use | 273 | 0 | 0% |
| Unk Juvederm Volux | Implant, dermal, for aesthetic use | 199 | 133 | 0% |
| Vollure Volume Unknown | Implant, dermal, for aesthetic use | 179 | 28 | 0% |
| JUVEDERM VOLBELLA XC 2 x 1mL 32G | Implant, dermal, for aesthetic use | 147 | 27 | 0% |
| Juvederm Ultra/24hv Volume Unknown | Implant, dermal, for aesthetic use | 138 | 9 | 0% |
| Juvederm Ultra Xc 1 Ml Coc | Implant, dermal, for aesthetic use | 130 | 0 | 0% |
| Juv Derm Voluma With Lidocaine | Implant, dermal, for aesthetic use | 129 | 50 | 0% |
| SKINVIVE by JUVEDERM XC 2x1 mL | Implant, dermal, for aesthetic use | 109 | 106 | 0.4% |
| JUVEDERM Volift w/Lido 2x1mL EAME SKU1 | Implant, dermal, for aesthetic use | 99 | 22 | 0% |
| UNK Dermal Filler | Implant, dermal, for aesthetic use | 56 | 25 | 0.5% |
| Unk Juvederm Volite | Implant, dermal, for aesthetic use | 38 | 54 | 0% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| LMH | Implant, dermal, for aesthetic use | 8,713 | 100% |
| FWM | Prosthesis, breast, inflatable, internal, saline | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Allergan Pringy reports
How many FDA device reports name Allergan Pringy as manufacturer?
8,714 reports through August 2026, 48 of them in the latest 12 months.
Which of its brands appear most often?
Juvederm Voluma Xc/Lido Volume Unknown (699), Juvederm Voluma XC 27G 2 x 1mL (664), VOLBELLA with LIDOCAINE (632), Juvederm Ultra Xc Tsk Us (560) and Unk Volbella (510).
Which device types does it report on?
implant, dermal, for aesthetic use (100%) and prosthesis, breast, inflatable, internal, saline (0%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.